| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |